TFAM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.890000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.371400E-01
Normal-vs-Stage2
4.492400E-01
Normal-vs-Stage3
2.792200E-01
Normal-vs-Stage4
9.829800E-01
Stage1-vs-Stage2
8.427200E-01
Stage1-vs-Stage3
7.605800E-02
Stage1-vs-Stage4
6.694200E-01
Stage2-vs-Stage3
9.610000E-04
Stage2-vs-Stage4
4.158000E-01
Stage3-vs-Stage4
2.384200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.854200E-01
Normal-vs-AfricanAmerican
7.630000E-01
Normal-vs-Asian
8.499800E-02
Caucasian-vs-AfricanAmerican
5.610500E-02
Caucasian-vs-Asian
1.178430E-01
AfricanAmerican-vs-Asian
6.360300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.317200E-01
Normal-vs-Female
4.882600E-01
Male-vs-Female
4.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.904400E-01
Normal-vs-Age(41-60Yrs)
8.303600E-01
Normal-vs-Age(61-80Yrs)
2.142400E-01
Normal-vs-Age(81-100Yrs)
3.683800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.102200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.695800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.101800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.498000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.747830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.263000E-01
Normal-vs-Daily Drinker
4.230000E-01
Normal-vs-Weekly Drinker
2.606800E-01
Normal-vs-Occasional Drinker
6.095200E-01
Normal-vs-Social Drinker
4.365200E-01
Non Drinker-vs-Daily Drinker
7.667800E-01
Non Drinker-vs-Weekly Drinker
9.724600E-01
Non Drinker-vs-Occasional Drinker
2.026000E-01
Non Drinker-vs-Social Drinker
5.337200E-01
Daily Drinker-vs-Weekly Drinker
8.341400E-01
Daily Drinker-vs-Occasional Drinker
4.436000E-01
Daily Drinker-vs-Social Drinker
7.998600E-01
Weekly Drinker-vs-Occasional Drinker
2.952000E-01
Weekly Drinker-vs-Social Drinker
6.091000E-01
Occasional Drinker-vs-Social Drinker
6.042200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.557600E-01
Normal-vs-Grade 2
8.079800E-01
Normal-vs-Grade 3
3.774200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.191000E-01
Grade 1-vs-Grade 3
2.106000E-01
Grade 1-vs-Grade 4
6.557600E-01
Grade 2-vs-Grade 3
3.372400E-01
Grade 2-vs-Grade 4
8.079800E-01
Grade 3-vs-Grade 4
3.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.067200E-01
Normal-vs-NonDiabetic
2.684400E-01
Diabetic-vs-NonDiabetic
6.287400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.258800E-01
Normal-vs-NoPancreatitis
2.926600E-01
Pancreatitis-vs-NoPancreatitis
6.179000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.027600E-01
Normal-vs-N1
4.717000E-01
N0-vs-N1
2.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.081600E-01
Normal-vs-TP53-NonMutant
5.694800E-01
TP53-Mutant-vs-TP53-NonMutant
2.677000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
